Announcements Trials
Browse Landscape

Phase

Phase 1 6Phase 2 5Phase 1/2 4Phase NA 2Phase 3 2

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1Dermatologic 1

Conditions

Breast Neoplasms 45Prostatic Neoplasms 41Brain Neoplasms 27Lung Neoplasms 19Glioblastoma 17Glioma 16Neoplasms 13Neoplasm Metastasis 13Carcinoma, Non-Small-Cell Lung 13Head and Neck Neoplasms 10Pancreatic Neoplasms 8Central Nervous System Neoplasms 8Uterine Cervical Neoplasms 7Lymphoma 7Carcinoma, Hepatocellular 7Rectal Neoplasms 6Oligodendroglioma 6Gliosarcoma 6Carcinoma, Squamous Cell 6Astrocytoma 6Squamous Cell Carcinoma of Head and Neck 5Esophageal Neoplasms 5Ependymoma 5Colorectal Neoplasms 5Carcinoma, Renal Cell 5Carcinoma, Intraductal, Noninfiltrating 5Sarcoma 4Meningioma 4Colonic Neoplasms 4Breast Neoplasms, Male 4

Interventions

Cyclophosphamide 15fludarabine phosphate 14Peripheral Blood Stem Cell Transplantation 12Cyclosporine 12Filgrastim 10Whole-Body Irradiation 9Mycophenolic Acid 9Busulfan 7Antilymphocyte Serum 7Melphalan 5fludarabine 4Radiotherapy 4Psychiatric Rehabilitation 4Methylprednisolone 4Methotrexate 4Etoposide 4Cord Blood Stem Cell Transplantation 4Therapeutics 3Rituximab 3Granulocyte Colony-Stimulating Factor 3Aprepitant 3Analgesia 3plerixafor 2Tacrolimus 2Ondansetron 2Magnetic Resonance Spectroscopy 2Flow Cytometry 2Dexamethasone 2Carmustine 2Calcium Dobesilate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, Mantle-Cell × Magnetic Resonance Spectroscopy × Clear all
NCT00504205 2013-08-02

MP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or Lymphoma

National Cancer Institute (NCI)

Phase NA Terminated
30 enrolled
DermatologicLymphoidOther hematologic neoplasm

Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Mycosis Fungoides, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Intraocular Lymphoma

NCT00110006 2010-06-11

Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma

Case Comprehensive Cancer Center

Phase NA Withdrawn
Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡